Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role.
Journal:
Atherosclerosis
PMID:
30658195
Abstract
BACKGROUND AND AIMS: The neuropeptide catestatin (CST) is an endogenous nicotinic cholinergic antagonist that acts as pleiotropic cardiac protective hormone. This study investigated the association between CST and coronary artery disease (CAD) and the underlying mechanisms.
Authors
Keywords
Angiotensin-Converting Enzyme 2
Animals
Anti-Inflammatory Agents
Atherosclerosis
Biomarkers
Case-Control Studies
Cell Adhesion Molecules
Cells, Cultured
Chromogranin A
Coronary Artery Disease
Cytokines
Disease Models, Animal
Down-Regulation
Female
Human Umbilical Vein Endothelial Cells
Humans
Male
Mice, Knockout, ApoE
Peptide Fragments
Peptidyl-Dipeptidase A
Plaque, Atherosclerotic
Severity of Illness Index